Cardinal Health, Inc. (NYSE:CAH) Shares Sold by West Oak Capital LLC

West Oak Capital LLC reduced its position in Cardinal Health, Inc. (NYSE:CAH) by 5.7% during the 1st quarter, according to its most recent filing with the SEC. The firm owned 2,080 shares of the company’s stock after selling 125 shares during the quarter. West Oak Capital LLC’s holdings in Cardinal Health were worth $233,000 as of its most recent filing with the SEC.

Several other institutional investors also recently bought and sold shares of the company. Cornerstone Wealth Management LLC purchased a new position in Cardinal Health in the 4th quarter valued at about $209,000. Mather Group LLC. lifted its stake in Cardinal Health by 2.5% during the fourth quarter. Mather Group LLC. now owns 6,678 shares of the company’s stock worth $673,000 after purchasing an additional 164 shares during the last quarter. Cambridge Investment Research Advisors Inc. lifted its stake in Cardinal Health by 86.8% in the fourth quarter. Cambridge Investment Research Advisors Inc. now owns 69,423 shares of the company’s stock valued at $6,998,000 after buying an additional 32,250 shares during the last quarter. Nordea Investment Management AB increased its holdings in shares of Cardinal Health by 50.5% during the fourth quarter. Nordea Investment Management AB now owns 184,537 shares of the company’s stock valued at $18,649,000 after purchasing an additional 61,933 shares during the period. Finally, Vest Financial LLC increased its holdings in shares of Cardinal Health by 15.9% during the fourth quarter. Vest Financial LLC now owns 282,440 shares of the company’s stock valued at $28,470,000 after purchasing an additional 38,769 shares during the period. 87.17% of the stock is owned by institutional investors and hedge funds.

Cardinal Health Price Performance

Shares of Cardinal Health stock traded down $1.22 on Tuesday, hitting $96.54. 1,822,267 shares of the company’s stock traded hands, compared to its average volume of 2,213,854. Cardinal Health, Inc. has a one year low of $85.11 and a one year high of $116.04. The company has a fifty day moving average of $99.64 and a two-hundred day moving average of $104.42. The company has a market capitalization of $23.51 billion, a price-to-earnings ratio of 42.91, a price-to-earnings-growth ratio of 1.11 and a beta of 0.61.

Cardinal Health (NYSE:CAH) last announced its earnings results on Thursday, May 2nd. The company reported $2.08 EPS for the quarter, beating the consensus estimate of $1.95 by $0.13. Cardinal Health had a negative return on equity of 54.74% and a net margin of 0.25%. The company had revenue of $54.90 billion for the quarter, compared to analyst estimates of $56.05 billion. During the same quarter in the prior year, the company earned $1.74 EPS. The firm’s revenue for the quarter was up 8.7% compared to the same quarter last year. Equities research analysts anticipate that Cardinal Health, Inc. will post 7.35 earnings per share for the current year.

Cardinal Health Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, July 15th. Investors of record on Monday, July 1st will be paid a dividend of $0.5056 per share. This is an increase from Cardinal Health’s previous quarterly dividend of $0.50. This represents a $2.02 dividend on an annualized basis and a yield of 2.09%. The ex-dividend date of this dividend is Monday, July 1st. Cardinal Health’s dividend payout ratio is 88.89%.

Wall Street Analyst Weigh In

A number of brokerages have commented on CAH. Wells Fargo & Company decreased their price objective on Cardinal Health from $96.00 to $94.00 and set an “underweight” rating for the company in a research report on Monday, April 29th. Argus dropped their price target on Cardinal Health from $120.00 to $115.00 and set a “buy” rating on the stock in a research report on Wednesday, May 15th. Evercore ISI boosted their price target on Cardinal Health from $110.00 to $115.00 and gave the company an “in-line” rating in a research note on Friday, May 3rd. StockNews.com lowered Cardinal Health from a “strong-buy” rating to a “buy” rating in a research note on Tuesday. Finally, Robert W. Baird cut their price target on Cardinal Health from $134.00 to $128.00 and set an “outperform” rating on the stock in a research note on Friday, May 3rd. One analyst has rated the stock with a sell rating, four have given a hold rating and eight have given a buy rating to the company. According to MarketBeat.com, Cardinal Health presently has an average rating of “Moderate Buy” and an average target price of $109.67.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.